| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 53166 |
| 1 | RITUXIMAB | 38502 |
| 2 | METHOTREXATE SODIUM | 38437 |
| 3 | INFLIXIMAB | 36963 |
| 4 | DENOSUMAB | 36484 |
| 5 | METHOTREXATE | 33470 |
| 6 | ACETAMINOPHEN | 32842 |
| 7 | ETANERCEPT | 22112 |
| 8 | ERGOCALCIFEROL | 21938 |
| 9 | VEDOLIZUMAB | 21828 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 14653 | 0.5303 |
| 1 | RITUXIMAB-ABBS | 2270 | 0.4791 |
| 2 | RITUXIMAB-PVVR | 2164 | 0.4625 |
| 3 | BOTULINUM TOXIN TYPE A | 4494 | 0.3842 |
| 4 | AZATHIOPRINE SODIUM | 909 | 0.3753 |
| 5 | PSEUDOEPHEDRINE HYDROCHLORIDE | 3472 | 0.3674 |
| 6 | IVOSIDENIB | 646 | 0.3536 |
| 7 | DEFIBROTIDE SODIUM | 1234 | 0.3521 |
| 8 | FARICIMAB | 2275 | 0.3496 |
| 9 | GOLD | 1908 | 0.3399 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 111964 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 77035 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 58473 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 46088 |
| 4 | Kinase Inhibitor [EPC] | 36877 |
| 5 | RANK Ligand Inhibitor [EPC] | 36484 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 34356 |
| 7 | Benzodiazepine [EPC] | 31733 |
| 8 | Atypical Antipsychotic [EPC] | 31488 |
| 9 | Vitamin C [EPC] | 24826 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cultured Cell [EPC] | 244 | 0.5661 |
| 1 | Interferon gamma Blocker [EPC] | 72 | 0.4162 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 303 | 0.3435 |
| 3 | Antileishmanial [EPC] | 113 | 0.3156 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 4976 | 0.3137 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 655 | 0.3014 |
| 6 | Colony Stimulating Factor-1 Receptor Blocker [EPC] | 25 | 0.2941 |
| 7 | Lead Chelator [EPC] | 23 | 0.2911 |
| 8 | Melanocortin 4 Receptor Agonist [EPC] | 59 | 0.2658 |
| 9 | Antidiarrheal [EPC] | 53 | 0.2585 |